Ionis Pharmaceuticals, Inc. Accounts Payable
Ionis Pharmaceuticals, Inc. (IONS) had Accounts Payable of $47.70 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-29
- 2026-06-30: Accounts Payable, Current $47.70M.
- 2026-03-31: Accounts Payable, Current $26.03M.
- 2025-12-31: Accounts Payable, Current $28.08M.
- 2025-09-30: Accounts Payable, Current $14.33M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $47.70M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $26.03M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $28.08M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $14.33M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $22.80M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $17.46M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $42.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $9.05M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $9.24M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $13.08M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $26.03M 10-K · filed 2025-02-19 |
| 2023-09-30 | $5.62M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $24.02M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.50M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $17.92M 10-K · filed 2024-02-21 |
| 2022-09-30 | $20.55M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $10.35M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.13M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $11.90M 10-K · filed 2023-02-22 |
| 2021-09-30 | $8.36M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $14.66M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $9.51M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $17.20M 10-K · filed 2022-02-25 |
| 2020-09-30 | $16.22M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $7.41M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $21.17M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $16.07M 10-K · filed 2021-02-24 |
| 2019-09-30 | $13.15M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $15.63M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $13.33M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $28.66M 10-K · filed 2020-03-02 |
| 2018-09-30 | $13.58M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $13.29M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $13.83M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $24.89M 10-K · filed 2019-03-01 |
| 2017-09-30 | $23.52M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $13.27M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $23.24M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $21.12M 10-K · filed 2018-02-28 |
| 2016-09-30 | $15.68M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $17.58M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $19.46M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $28.36M 10-K · filed 2017-03-01 |
| 2015-09-30 | $19.29M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $10.95M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $16.49M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $17.98M 10-K · filed 2016-02-26 |
| 2014-09-30 | $15.63M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $13.45M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $9.87M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $11.01M 10-K · filed 2015-03-02 |
| 2013-09-30 | $8.78M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $9.46M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $5.38M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $10.24M 10-K · filed 2014-03-03 |
| 2012-09-30 | $5.26M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $6.19M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $5.34M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $8.30M 10-K · filed 2013-02-28 |
| 2011-09-30 | $6.65M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $3.07M 10-Q · filed 2011-08-08 |
| 2011-03-31 | $4.65M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $6.52M 10-K · filed 2012-02-29 |
| 2010-09-30 | $3.39M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $5.36M 10-Q · filed 2010-08-09 |
| 2009-12-31 | $4.70M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |